In MS, iron rim lesions tied to severe disability, more brain damage
A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim lesions.| Multiple Sclerosis News Today
A team of scientists analyzed data from over a dozen studies involving more than 900 people with MS to research iron rim lesions.| Multiple Sclerosis News Today
Exercise effectively eases fatigue and improves muscular fitness in MS patients, but the best type differs for each outcome, per an analysis.| Multiple Sclerosis News Today
Vibration therapy eases fatigue and improves motor and cognitive outcomes in MS, outperforming standard physical exercise alone in a trial.| Multiple Sclerosis News Today
Get the latest multiple sclerosis news, patient views, and caregiver perspectives from one of the largest MS communities online.| Multiple Sclerosis News Today
Columnist Desiree Lama pens an open letter to her present-day self, who is in need of some support and encouragement while living with MS.| Multiple Sclerosis News Today
People with MS who experience chronic lower body pain have altered gait patterns, walking more slowly than those without this symptom.| Multiple Sclerosis News Today
Task-oriented training may help balance issues for people with MS, but current evidence is inconsistent, a study found.| Multiple Sclerosis News Today
Rebif (interferon beta-1a) is a disease-modifying therapy for relapsing forms of MS. Learn about its uses, indications, and side effects.| Multiple Sclerosis News Today
Ocrevus (ocrelizumab) is an infusion therapy approved to treat adults with relapsing forms of MS and primary progressive MS.| Multiple Sclerosis News Today
Ibudilast was shown on MRI scans to slow the growth of chronic active lesions in the brains of progressive MS patients in the SPRINT-MS trial.| Multiple Sclerosis News Today
The presence of two distinct chronic lesion markers on MRI is linked to faster disability progression in MS patients, researchers say.| Multiple Sclerosis News Today
If you've just received a multiple sclerosis (MS) diagnosis, a good place to start is by gathering info on MS and how to best manage it.| Multiple Sclerosis News Today
A multiple sclerosis relapse or flare-up occurs when symptoms suddenly worsen or intensify before easing over a period of time.| Multiple Sclerosis News Today
A growing body of evidence has suggested EBV is a major environmental risk factor for MS. Learn more about its association with the disease.| Multiple Sclerosis News Today
Transcranial direct current stimulation (tDCS) didn't outperform a sham treatment in easing fatigue in adults with multiple sclerosis.| Multiple Sclerosis News Today
Certain immune cells in MS show abnormalities in activity and signs of reactions against the Epstein-Barr virus, a study says.| Multiple Sclerosis News Today
In MS, slowly expanding lesions were linked to more myelin loss in brain regions of damage and in normal-appearing brain tissue, per a study.| Multiple Sclerosis News Today
Columnist Ben Hofmeister offers insight into his strategy of learning about MS care by using knowledge he already has.| Multiple Sclerosis News Today
Living with a chronic illness such as multiple sclerosis (MS) can lead to mental health challenges, such as depression and anxiety.| Multiple Sclerosis News Today
Cognitive impairment has been a challenging symptom of multiple sclerosis for columnist Desiree Lama. Here's how she copes with it.| Multiple Sclerosis News Today
Marisa Wexler is a senior science writer for Multiple Sclerosis News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of multiple sclerosis topics.| Multiple Sclerosis News Today
Many people with MS experience heat intolerance. Triggers can include hot weather, increases in body temperature after exercise, or fever.| Multiple Sclerosis News Today
Gilenya (fingolimod) is a disease-modifying therapy for relapsing forms of MS. Learn more about its uses, indications, and side effects.| Multiple Sclerosis News Today
Migraines affect around 24% of people with MS, and are about two times more likely to occur in these patients than in healthy individuals.| Multiple Sclerosis News Today
There are several approved MS medications, from disease-modifying therapies to symptomatic treatments. Learn more about them here.| Multiple Sclerosis News Today
MRI is an imaging technique that can aid in diagnosing MS. Learn more about how this tool is used to detect MS and assess damage in the CNS.| Multiple Sclerosis News Today
Columnist Leigh Anne Nelson, who's undergone many scans, offers readers her lessons in how to prepare for an MRI.| Multiple Sclerosis News Today
Fampyra (fampridine), which is approved to boost walking ability in adults with MS, may help people with poor working memory, a study says.| Multiple Sclerosis News Today
Columnist Jennifer Powell describes her experience dealing with heat, which tends to worsen her MS symptoms.| Multiple Sclerosis News Today
Read about multiple sclerosis support groups, which can help patients, families, caregivers and others from feeling that they're all alone.| Multiple Sclerosis News Today
When it comes to managing MS, what works for me might not work for you, and vice versa, says columnist Ben Hofmeister.| Multiple Sclerosis News Today
In the years since her MS diagnosis, columnist Desiree Lama has learned the importance of accepting help and support from loved ones.| Multiple Sclerosis News Today
MS is categorized into four main types: CIS, RRMS, SPMS, and PPMS. Learn more about each different type, their presentation, and treatment.| Multiple Sclerosis News Today
Abata Therapeutics has chosen its first treatment candidate for development: the T-cell therapy ABA-101 for certain forms of progressive MS.| Multiple Sclerosis News Today
People with MS show similar changes in gut microbiome that are consistent across the U.S. and Asia, an analysis of studies showed.| Multiple Sclerosis News Today
Disease-modifying therapies, known as DMTs, are treatments that can reduce the activity and progression of multiple sclerosis (MS).| Multiple Sclerosis News Today
SPMS is defined by MS symptoms gradually worsening over time, even in the absence of relapse activity. Learn more about symptoms and diagnosis.| Multiple Sclerosis News Today
Rituximab is commonly used off-label in multiple sclerosis patients. Learn more about its uses, side effects, and clinical testing.| Multiple Sclerosis News Today
PPMS is characterized by steadily worsening MS symptoms over time. Learn more about symptoms and diagnosis.| Multiple Sclerosis News Today
Fatigue was shown to be a significant predictor of worse health-related quality of life in adults with relapsing-remitting multiple sclerosis.| Multiple Sclerosis News Today
Patricia Inacio is a science writer for Multiple Sclerosis News Today with a PhD in cell biology. She covers the latest news and information on a variety of multiple sclerosis topics.| Multiple Sclerosis News Today
Bionews employs science writers and editors, most of whom have PhDs in the life sciences, as well as veteran journalists, to ensure news and information is well-written, accurate, and easy to understand.| Multiple Sclerosis News Today
Rehabilitation neuropsychologist Meghan Beier, PhD, answers questions about managing MS fatigue in this month's "Expert Voices."| Multiple Sclerosis News Today
Columnist Desiree Lama shares how a diagnosis of MS both halted her from scholastic pursuits and shifted her in a new direction.| Multiple Sclerosis News Today
Support and companionship are just a few benefits of having a cat, says columnist Desiree Lama, who writes about her furry friend, Lucky.| Multiple Sclerosis News Today
In this month's Expert Voices, physical therapist Mandy Rohrig answers readers' questions about exercising with multiple sclerosis.| Multiple Sclerosis News Today
Columnist Susan Payrovi discovers how her body prefers to follow natural circadian rhythms, or biological clocks.| Multiple Sclerosis News Today
A study in a mouse model of multiple sclerosis showed the body's internal biological clock — known as circadian rhythm — influences immune system responses.| Multiple Sclerosis News Today
Learning to say no and prioritize her health has been crucial for columnist Desiree Lama, who lives with relapsing-remitting MS.| Multiple Sclerosis News Today
Category archive page for News.| Multiple Sclerosis News Today
In her columns debut, Desiree Lama shares the story of how vision loss and optic neuritis led to her multiple sclerosis diagnosis in 2016.| Multiple Sclerosis News Today
No description.| Multiple Sclerosis News Today
RRMS is defined by periods of new or worsening symptoms followed by periods of remission. Learn more about symptoms and diagnosis.| Multiple Sclerosis News Today
Spending time outdoors helps columnist Susan Payrovi wake up her body systems and manage her multiple sclerosis symptoms.| Multiple Sclerosis News Today
Symptoms and early signs of MS vary from person to person. Common symptoms include movement problems, pain, fatigue, and vision problems.| Multiple Sclerosis News Today
Living with MS to the fullest may mean making positive choices about your physical and mental health: here are some tips.| Multiple Sclerosis News Today
No cure exists yet for multiple sclerosis, but there are several treatment options that can help manage MS symptoms, progression, and attacks.| Multiple Sclerosis News Today
Several tests, including MRI and blood tests, can be used to diagnose MS. Learn more about testing and what to expect after a diagnosis.| Multiple Sclerosis News Today
With 17 piercings, columnist Desiree Lama had to find ways to accommodate annual MRIs, considering all the jewelry she wears.| Multiple Sclerosis News Today
Category archive page for Columns.| Multiple Sclerosis News Today
No one knows your needs as well as you do, says columnist Ben Hofmeister. That's why self-advocating is crucial when living with MS.| Multiple Sclerosis News Today
Concerned about mild MS progression identified in an MRI of brain lesions, columnist Desiree Lama decides to change treatments.| Multiple Sclerosis News Today
After a year, patients given CNM-Au8 had improvements in vision and data suggested the therapy improved the health of brain nerve fibers.| Multiple Sclerosis News Today
The exact causes of MS are not known, but several factors, such as genetic factors, infection, and demographics, are linked to MS development.| Multiple Sclerosis News Today
In MS, the myelin sheath is damaged by the immune system's inflammatory attack. Learn more about its function and how it relates to MS.| Multiple Sclerosis News Today
MS is not usually fatal, but it may increase the risk of life-threatening complications. Learn more about MS progression and life expectancy.| Multiple Sclerosis News Today
MS is defined by the presence of lesions in the nervous system. Learn more about MS lesions and view a picture of what brain lesions look like on an MRI.| Multiple Sclerosis News Today
While diet cannot replace treatment, studies suggest that a balanced diet may help patients to better manage and control multiple sclerosis.| Multiple Sclerosis News Today
Life with MS isn't like a race that has a finish line, says columnist Ahna Crum, who's had to relearn how to maintain good health.| Multiple Sclerosis News Today
Columnist Ben Hofmeister says MS is part of who he is, but he maintains the essence of himself without letting MS define him.| Multiple Sclerosis News Today
Iaso Bio has received clearance from the FDA to start clinical trials to test its CAR T-cell therapy equecabtagene autoleucel in MS patients.| Multiple Sclerosis News Today
Certain immune cells are able to take on healing abilities allowing them to repair damaged nerve fibers, a possible strategy for treating MS.| Multiple Sclerosis News Today
The relationship between cognitive issues and quality of life was analyzed with a survey of 6,227 people using the NARCOMS registry.| Multiple Sclerosis News Today
A $2.9 million research grant will fund a project aiming to advance a new technology to improve stem cell therapies for multiple sclerosis.| Multiple Sclerosis News Today
Most nonactive SPMS patients who took foralumab nasal spray for at least six months saw a decrease in microglial activity in their brains.| Multiple Sclerosis News Today
Cognitive rehabilitation, with or without aerobic exercise, led to increased tissue volume and activity in brain regions linked to cognition.| Multiple Sclerosis News Today
Many MS patients experience primary headaches, and disease-modifying therapies may play different roles in their development, per a study.| Multiple Sclerosis News Today
Before MS, columnist Susan Payrovi thrived after dark. Now, she's honoring her body's rhythms and reaping the benefits of natural light.| Multiple Sclerosis News Today
MS is an autoimmune disease that affects the central nervous system. Learn more about MS types, causes, symptoms, diagnosis, and treatment.| Multiple Sclerosis News Today
